Cited by 5,983SARS-CoV-2 and COVID-19 ResearchEnzyme Structure and FunctionAnimal Virus Infections Studies

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Open access

Lan, Jun, Ge, Jiwan, Yu, Jinfang, Shan, Sisi, Zhou, Huan, Fan, Shilong, Zhang, Qi, Shi, Xuanling, Wang, Qisheng, Zhang, Linqi, Wang, Xinquan·2020·Nature

DOI 10.1038/s41586-020-2180-5

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world 1-3. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor 4. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses 1-3,5. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2180-5

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citation
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citation
La certeza de lo impredecible
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961

Show all 38 references

Sorted by citations

Items 701–800 of 1,026

SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
Yang, Z., Han, Y., Ding, S., Shi, W., Zhou, T., Finzi, A., Kwong, P. D., Mothes, W., & Lu, M. (2022) · mBio · doi:10.1128/mbio.03227-21 · Cited by 78
Advances in the Development of SARS-CoV-2 Mpro Inhibitors
Agost-Beltrán, L., de la Hoz‐Rodríguez, S., Bou‐Iserte, L., Rodríguez, S., Fernández-de-la-Pradilla, A., & González, F. V. (2022) · Molecules · doi:10.3390/molecules27082523 · Cited by 78
An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
Barnett, K. C., Xie, Y., Asakura, T., Song, D., Liang, K., Taft-Benz, S., Guo, H., Yang, S., Okuda, K., Gilmore, R. C., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.12.005 · Cited by 78
Multidrug treatment with nelfinavir and cepharanthine against COVID-19Preprint
Ohashi, H., Watashi, K., Saso, W., Shionoya, K., Iwanami, S., Hirokawa, T., Shirai, T., Kanaya, S., Ito, Y., Kim, K. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.14.039925 · Cited by 78
Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex
Laurini, E., Marson, D., Aulić, S., Fermeglia, M., & Pricl, S. (2020) · ACS Nano · doi:10.1021/acsnano.0c04674 · Cited by 77
The Perfect Storm: COVID-19 Health Disparities in US Blacks
Phillips, N., Park, I.-W., Robinson, J. R., & Jones, H. P. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00871-y · Cited by 77
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
Xiang, R., Yu, Z., Wang, Y., Wang, L., Huo, S., Li, Y., Liang, R., Hao, Q., Ying, T., Gao, Y., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.016 · Cited by 77
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
Wang, L., Wu, Y. L., Yao, S., Ge, H., Zhu, Y., Chen, K., Chen, W., Zhang, Y., Zhu, W. J., Wang, H., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00735-z · Cited by 77
Self-citation
Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions
Dudas, G., Hong, S. L., Potter, B. I., Calvignac‐Spencer, S., Niatou-Singa, F. S., Tombolomako, T. B., Neba, T. F., Vickos, U., Ulrich, M., Leendertz, F. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26055-8 · Cited by 77
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Smith, K. N., Clark, S. A., Shankar, S., Pan, J., Clark, L. E., Yang, P., Coscia, A., McKay, L. G. A., Varnum, H., Brusic, V., et al. (2022) · Science · doi:10.1126/science.abl6251 · Cited by 77
Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo
Port, J. R., Yinda, C. K., Avanzato, V. A., Schulz, J. E., Holbrook, M. G., van Doremalen, N., Shaia, C., Fischer, R. J., & Munster, V. J. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01047-y · Cited by 77
A broad and potent neutralization epitope in SARS-related coronaviruses
Yuan, M., Zhu, X., He, W., Zhou, P.-P., Kaku, C. I., Capozzola, T., Zhu, C. Y., Yu, X., Liu, H., Yu, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205784119 · Cited by 77
Computational Prediction of Mutational Effects on SARS-CoV‑2 Binding by Relative Free Energy Calculations
Zou, J., Yin, J., Fang, L., Yang, M., Wang, T., Wu, W., Bellucci, M. A., & Zhang, P. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00679 · Cited by 76
Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
Jeong, G. U., Song, H., Yoon, G. Y., Kim, D., & Kwon, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01723 · Cited by 76
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
Tumban, E. (2020) · Viruses · doi:10.3390/v13010054 · Cited by 76
Association of smoking history with severe and critical outcomes in COVID-19 patients: A systemic review and meta-analysis
Zhang, H., Ma, S., Han, T., Qu, G., Cheng, C., Uy, J. P., Shaikh, M. B., Zhou, Q., Song, E. J., & Sun, C. (2021) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2021.101313 · Cited by 76
SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system
Verma, S., Joshi, C. S., Silverstein, R. B., He, M., Carter, E. B., & Mysorekar, I. U. (2021) · Med · doi:10.1016/j.medj.2021.04.009 · Cited by 76
Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19
Hassler, L., Reyes, F., Sparks, M. A., Welling, P. A., & BATLLE, D. C. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04560421 · Cited by 76
Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2
Yadav, R., Hasan, S., Mahato, S. K., Çelik, İ., Mary, Y. S., Kumar, A., Dhamija, P., Sharma, A., Choudhary, N., Chaudhary, P. K., et al. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116942 · Cited by 76
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
Samelson, A. J., Tran, Q. D., Robinot, R., Carrau, L., Rezelj, V. V., Kain, A. M., Chen, M., Ramadoss, G. N., Guo, X., Lim, S. A., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00821-8 · Cited by 76
Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
Liu, J., Lü, F., Chen, Y., Plow, E. F., & Qin, J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101710 · Cited by 76
SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
He, P., Liu, B., Gao, X., Yan, Q., Pei, R., Sun, J., Chen, Q., Hou, R., Li, Z., Zhang, Y., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01235-4 · Cited by 76
Self-citation
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Li, X., Yuan, H., Li, X., & Wang, H. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28212 · Cited by 76
In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infectionPreprint
Pandit, M., & Latha, N. (2020) · doi:10.21203/rs.3.rs-22687/v1 · Cited by 76
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
Sharun, K., Tiwari, R., Yatoo, M. I., Patel, S. K., Natesan, S., Dhama, J., Malik, Y. S., Harapan, H., Singh, R. K., & Dhama, K. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1796963 · Cited by 75
Potential therapeutic effects of Resveratrol against SARS-CoV-2
Ramdani, L. H., & Bacharı, K. (2020) · Acta Virologica · doi:10.4149/av_2020_309 · Cited by 75
Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
Ma, H., Zeng, W., Meng, X., Huang, X., Yang, Y., Zhao, D., Zhou, P., Wang, X., Zhao, C., Sun, Y. C., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02438-20 · Cited by 75
Self-citation
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
Asarnow, D. E., Wang, B., Lee, W.-H. S., Hu, Y., Huang, C.-W., Faust, B., Ng, P. M. L., Ngoh, E. Z. X., Bohn, M., Bulkley, D. P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.033 · Cited by 75
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
Parker, R., Partridge, T., Wormald, C., Kawahara, R., Stalls, V., Aggelakopoulou, M., Parker, J., Doherty, R. P., Ariosa-Morejon, Y., Lee, E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109179 · Cited by 75
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
Rujas, E., Kucharska, I., Tan, Y. Z., Benlekbir, S., Cui, H., Zhao, T., Wasney, G. A., Budylowski, P., Guvenc, F., Newton, J. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23825-2 · Cited by 75
Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry
Roberts, D. S., Mann, M. W., Melby, J. A., Larson, E. J., Zhu, Y., Brasier, A. R., Jin, S., & Ge, Y. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c02713 · Cited by 75
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Planchais, C., Fernández, I., Bruel, T., de Melo, G. D., Prot, M., Beretta, M., Guardado‐Calvo, P., Dufloo, J., Molinos-Albert, L. M., Backović, M., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220638 · Cited by 75
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
He, C., Yang, J., Hong, W., Chen, Z., Peng, D., Hong, L., Alu, A., He, X., Bi, Z., Jiang, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33209-9 · Cited by 75
Assassination and the Law of Armed Conflict
Zengel, P. (1991) · eYLS (Yale Law School) · Cited by 75
Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO—A “Living Working Document”
Rajagopal, K., Keller, S. P., Akkanti, B. H., Bime, C., Loyalka, P., Cheema, F. H., Zwischenberger, J. B., Banayosy, A. E., Pappalardo, F., Slaughter, M. S., et al. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001180 · Cited by 74
Targeted therapy strategies against SARS‐CoV‐2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
Seyedpour, S., Khodaei, B., Loghman, A. H., Seyedpour, N., Kisomi, M. F., Balibegloo, M., Nezamabadi, S. S., Gholami, B., Saghazadeh, A., & Rezaei, N. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30032 · Cited by 74
Graphene Sheets with Defined Dual Functionalities for the Strong SARS‐CoV‐2 Interactions
Donskyi, I. S., Nie, C., Ludwig, K., Trimpert, J., Ahmed, R., Quaas, E., Achazi, K., Radnik, J., Adeli, M., Haag, R., et al. (2021) · Small · doi:10.1002/smll.202007091 · Cited by 74
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
Yi, C., Sun, X., Lin, Y., Gu, C., Ding, L., Lü, X., Yang, Z., Zhang, Y., Ma, L., Gu, W., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00985-w · Cited by 74
A scoping review of the pathophysiology of COVID-19
Marik, P. E., Iglesias, J. I., Varón, J., & Kory, P. D. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211048026 · Cited by 74
Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
Ren, W., Lan, J., Ju, X., Gong, M., Long, Q., Zhu, Z., Yu, Y., Wu, J., Zhong, J., Zhang, R., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010053 · Cited by 74
Self-citation
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
Huang, Y., Borisov, O., Kee, J. J., Carpp, L. N., Wrin, T., Cai, S., Sarzotti‐Kelsoe, M., McDanal, C. B., Eaton, A., Pajón, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03154-6 · Cited by 74
Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis
Thomas, S., Smatti, M. K., Ouhtit, A., Cyprian, F. S., Almaslamani, M., Thani, A. A., & Yassine, H. M. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.11.010 · Cited by 74
Current Status of COVID‐19 (Pre)Clinical Vaccine Development
Ye, T., Zhong, Z., García‐Sastre, A., Schotsaert, M., & Geest, B. G. D. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008319 · Cited by 73
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients with COVID‐19: A rapid systematic review and meta‐analysis
Liu, X., Long, C., Xiong, Q., Chen, C., Ma, J., Su, Y., & Hong, K. (2020) · Clinical Cardiology · doi:10.1002/clc.23421 · Cited by 73
Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
Capcha, J. M. C., Lambert, G., Dykxhoorn, D. M., Salerno, A. G., Hare, J. M., Whitt, M. A., Pahwa, S. G., Jayaweera, D. T., & Shehadeh, L. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.618651 · Cited by 73
Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide
Khelashvili, G., Plante, A., Doktorova, M., & Weinstein, H. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.023 · Cited by 73
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
Fantini, J., Yahi, N., Azzaz, F., & Chahinian, H. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.06.001 · Cited by 73
PCR performance in the SARS-CoV-2 Omicron variant of concern?
Metzger, C., Lienhard, R., Seth-Smith, H. M. B., Roloff, T. C., Wegner, F., Sieber, J., Bel, M., Greub, G., & Egli, A. (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.w30120 · Cited by 73
Lysine-Targeted Reversible Covalent Ligand Discovery for Proteins via Phage Display
Zheng, M., Chen, F., Li, K., Reja, R. M., Hæffner, F., & Gao, J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c07375 · Cited by 73
Intermediates in SARS-CoV-2 spike–mediated cell entry
Marcink, T. C., Kicmal, T., Armbruster, E., Zhang, Z., Zipursky, G., Golub, K., Idris, M., Khao, J., Drew-Bear, J., McGill, G. G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo3153 · Cited by 73
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
Gozalbo‐Rovira, R., Giménez, E., Latorre, V., Francés‐Gómez, C., Albert, E., Buesa, J., Marina, A., Blasco, M. L., Signes‐Costa, J., Rodríguez‐Díaz, J., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104611 · Cited by 72
A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection
Aktaş, G. (2020) · Experimental Biomedical Research · doi:10.30714/j-ebr.2020463629 · Cited by 72
Molecular Basis of SARS-CoV‑2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches
Francés‐Monerris, A., Hognon, C., Miclot, T., García‐Iriepa, C., Iriepa, I., Terenzi, A., Grandemange, S., Barone, G., Marazzi, M., & Monari, A. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00779 · Cited by 72
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
Tada, T., Fan, C., Chen, J., Kaur, R., Stapleford, K. A., Gristick, H. B., Dcosta, B. M., Wilen, C. B., Nimigean, C. M., & Landau, N. R. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108528 · Cited by 72
Kidney injury molecule-1 is a potential receptor for SARS-CoV-2
Yang, C., Zhang, Y. L., Zeng, X., Chen, H., Chen, Y., Yang, D., Shen, Z., Wang, X., Liu, X., Xiong, M., et al. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab003 · Cited by 72
Self-citation
Genetic and epigenetic factors associated with increased severity of Covid‐19
Yildirim, Z., Sahin, O. S., Yazar, S., & Çetintaş, V. B. (2021) · Cell Biology International · doi:10.1002/cbin.11572 · Cited by 72
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
Yan, R., Wang, R., Ju, B., Yu, J., Zhang, Y., Liu, N., Wang, J., Zhang, Q., Chen, P., Zhou, B., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00487-9 · Cited by 72
Self-citation
SARS-CoV-2: is there neuroinvasion?
McQuaid, C., Brady, M., & Deane, R. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00267-y · Cited by 72
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
Koehler, M., Ray, A., Moreira, R. A., Juniku, B., Poma, A. B., & Alsteens, D. (2021) · Nature Communications · doi:10.1038/s41467-021-27325-1 · Cited by 72
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
Mousavi, S. S., Karami, A., Haghighi, T. M., Tumilaar, S. G., Fatimawali, F., Idroes, R., Mahmud, S., Çelik, İ., Ağagündüz, D., Tallei, T. E., et al. (2021) · Molecules · doi:10.3390/molecules26185724 · Cited by 72
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Chen, F., Zhang, Y., Li, X., Li, W., Liu, X., & Xue, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.753721 · Cited by 72
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
Lan, J., He, X., Ren, Y., Wang, Z., Zhou, H., Fan, S., Zhu, C., Liu, D., Shao, B., Liu, T., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00644-8 · Cited by 72
Self-citation
Advances in Research on Antiviral Activities of Sulfated Polysaccharides from Seaweeds
Wei, Q., Fu, G., Wang, K., Yang, Q., Zhao, J., Wang, Y., Ji, K., & Song, S. (2022) · Pharmaceuticals · doi:10.3390/ph15050581 · Cited by 72
Genetic diversity and evolutionary convergence of cryptic SARS- CoV-2 lineages detected via wastewater sequencing
Gregory, D. A., Trujillo, M., Rushford, C., Flury, A. G., Kannoly, S., San, K. M., Lyfoung, D. T., Wiseman, R. W., Bromert, K. H., Zhou, M.-Y., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010636 · Cited by 72
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Li, M., Ren, Y., Aw, Z. Q., Chen, B., Yang, Z., Lei, Y., Cheng, L., Liang, Q., Hong, J., Yang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35642-2 · Cited by 72
Self-citation
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 72
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
Shirin, T., Bhuiyan, T. R., Charles, R. C., Amin, S., Bhuiyan, I., Kawser, Z., Rahat, A., Alam, A. N., Sultana, S., Aleem, M. A., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1484 · Cited by 71
Nucleic Acid Testing of SARS-CoV-2
Yoo, H. M., Kim, I.-H., & Kim, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116150 · Cited by 71
Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19
Parihar, A., Sonia, Z. F., Akter, F., Ali, M., Hakim, F. T., & Hossain, M. S. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105468 · Cited by 71
SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020
Alkhovsky, S. V., Lenshin, S. V., Romashin, A. V., Владимировна, В. Т., Vyshemirsky, O. I., Bulycheva, Y. I., Dk, L., & Gitelman, A. K. (2022) · Viruses · doi:10.3390/v14010113 · Cited by 71
Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer
Fernández-García, R., & Fraguas‐Sánchez, A. I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121584 · Cited by 71
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
Zheng, Y., Larragoite, E. T., Lama, J., Cisneros, I., Delgado, J. C., Slev, P. R., Rychert, J., Innis, E. A., Williams, E. S. C. P., Coiras, M., et al. (2021) · Virology Journal · doi:10.1186/s12985-020-01472-1 · Cited by 71
Single‐cell RNA analysis on ACE2 expression provides insights into SARS‐CoV‐2 potential entry into the bloodstream and heart injury
Guo, J., Wei, X., Li, Q., Li, L., Yang, Z., Shi, Y., Qin, Y., Zhang, X., Wang, X., Zhi, X., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29802 · Cited by 70
Self-citation
Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2
Li, L., Sun, T., He, Y., Wendong, L., Yubo, F., & Jing, Z. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198082 · Cited by 70
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
Aita, A., Basso, D., Cattelan, A. M., Fioretto, P., Navaglia, F., Barbaro, F., Stoppa, A., Coccorullo, E., Farella, A., Socal, A., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.09.018 · Cited by 70
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis
Han, Y., Jia, Z., Shi, J., Wang, W., & He, K. (2021) · Bioimpacts · doi:10.34172/bi.2021.23378 · Cited by 70
Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
Ma, Z., Yang, Y., Huang, Y., & Lui, K. O. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.11.010 · Cited by 70
Navigating with chemometrics and machine learning in chemistry
Joshi, P. B. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-023-10391-w · Cited by 70
Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications
Strafella, C., Caputo, V., Termine, A., Barati, S., Gambardella, S., Borgiani, P., Caltagirone, C., Novelli, G., Giardina, E., & Cascella, R. (2020) · Genes · doi:10.3390/genes11070741 · Cited by 69
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
Calcagnile, M., Forgez, P., Iannelli, A., Bucci, C., Alifano, M., & Alifano, P. (2020) · Biochimie · doi:10.1016/j.biochi.2020.11.004 · Cited by 69
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Townsend, A., Rijal, P., Xiao, J. H., Tan, T. K., Huang, K.-Y. A., Schimanski, L. M., Huo, J., Gupta, N., Rahikainen, R., Matthews, P. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22045-y · Cited by 69
Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis
Gong, F., Wei, H.-X., Qi, J., Ma, H., Liu, L., Weng, J., Zheng, X., Li, Q., Zhao, D., Fang, H., et al. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00773 · Cited by 69
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Mast, F. D., Fridy, P. C., Ketaren, N. E., Wang, J., Jacobs, E. Y., Olivier, J. P., Sanyal, T., Molloy, K. R., Schmidt, F., Rutkowska, M., et al. (2021) · eLife · doi:10.7554/elife.73027 · Cited by 69
Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1
Geng, Q., Shi, K., Ye, G., Zhang, W., Aihara, H., & Li, F. (2022) · Journal of Virology · doi:10.1128/jvi.00249-22 · Cited by 69
Gestational diabetes mellitus and COVID-19: results from the COVID-19–Related Obstetric and Neonatal Outcome Study (CRONOS)
Kleinwechter, H. J., Weber, K. S., Mingers, N., Ramsauer, B., Schaefer-Graf, U. M., Groten, T., Kuschel, B., Backes, C., Banz‐Jansen, C., Berghäuser, M. A., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.05.027 · Cited by 69
Iron and iron-related proteins in COVID-19
Suriawinata, E., & Mehta, K. J. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00851-y · Cited by 69
SARS-CoV-2’s Variants of Concern: A Brief Characterization
Scovino, A. M., Dahab, E. C., Vieira, G. F., Freire‐de‐Lima, L., Freire-de-Lima, C. G., & Morrot, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834098 · Cited by 69
An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
Fernández, M. L., Santiago, G. C., Martín-Dunn, A. M., Gonzalez-Roche, D., Béquet‐Romero, M., Márquez, G., González-Moya, I., Canaán-Haden, C., Cabrales, A., Espinosa, L. A., et al. (2022) · New Biotechnology · doi:10.1016/j.nbt.2022.08.002 · Cited by 69
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
Zhou, T., Teng, I., Olia, A. S., Cerutti, G., Gorman, J., Nazzari, A. F., Shi, W., Tsybovsky, Y., Wang, L., Wang, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108322 · Cited by 69
DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
Cleri, F., Lensink, M. F., & Blossey, R. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.713003 · Cited by 68
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection
Prasansuklab, A., Theerasri, A., Rangsinth, P., Sillapachaiyaporn, C., Chuchawankul, S., & Tencomnao, T. (2020) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2020.12.001 · Cited by 68
Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein
Mori, T., Jung, J., Kobayashi, C., Dokainish, H., Re, S., & Sugita, Y. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.01.012 · Cited by 68
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Roberts, J., Pritchard, A. L., Treweeke, A. T., Rossi, A. G., Brace, N., Cahill, P. A., MacRury, S. M., Wei, J., & Megson, I. L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.629933 · Cited by 68
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
Pasini, A. M. F., Stranieri, C., Cominacini, L., & Mozzini, C. (2021) · Antioxidants · doi:10.3390/antiox10020272 · Cited by 68
Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
Yang, L., Chen, R. H., Hamdoun, S., Coghi, P. S., Ng, J. P. L., Zhang, D. W., Guo, X., Xia, C., Law, B. Y. K., & Wong, V. K. W. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153591 · Cited by 68
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective
Khan, A., Gui, J., Ahmad, W., Haq, I., Shahid, M., Khan, A. A., Shah, A., Khan, A., Ali, L., Anwar, Z., et al. (2021) · RSC Advances · doi:10.1039/d1ra04694b · Cited by 68
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
Ahmad, I., Pawara, R. H., Surana, S. J., & Patel, H. (2021) · Topics in Current Chemistry · doi:10.1007/s41061-021-00353-7 · Cited by 68
B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies
Zhan, Y., Yin, H. Y., & Yin, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66881 · Cited by 68
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Polatoğlu, İ., Öner, T. Ö., Dalman, I., & Ozdogan, S. (2023) · MedComm · doi:10.1002/mco2.228 · Cited by 68
In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS‐CoV‐2: A Molecular Docking and Dynamics Simulation Approach
Halder, S. K., Sultana, I., Shuvo, M. I. M., Shil, A., Himel, M. K., Hasan, M. A., & Shawan, M. M. A. K. (2023) · BioMed Research International · doi:10.1155/2023/5469258 · Cited by 68

Authors: Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X.
Affiliations: Tsinghua University (CN)
Chinese Academy of Sciences (CN)
Corresponding author: Zhang, Qi
Zhang, Linqi
Wang, Xinquan
ORCID: Lan, Jun
Ge, Jiwan
Yu, Jinfang
Shan, Sisi
Zhou, Huan
Fan, Shilong
Zhang, Qi
Shi, Xuanling
Wang, Qisheng
Zhang, Linqi
Wang, Xinquan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-03-30
Volume: 581
Issue: 7807
Pages: 215-220
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2180-5
OpenAlex: W3014067025
Cited by: 5,983
References: 38
Citations by year: 2026: 207 · 2025: 404 · 2024: 573 · 2023: 797 · 2022: 1237 · 2021: 1678 · 2020: 1076
FWCI: 152.41
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Salt Science Research Foundation
Tencent
Tsinghua University (20201080053)
Beijing Municipal Science and Technology Commission (171100000517-001 and -003)
Beijing Advanced Innovation Center for Structural Biology, Tsinghua University
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: SARS-CoV-2, spike protein, receptor binding domain, ACE2, crystal structure, SARS-CoV, convergent evolution, antibody epitopes, cross-reactive antibodies, viral entry, binding site residues
MeSH terms: Protein Domains, Betacoronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Amino Acid Sequence, Epitopes, Binding Sites, Humans, Hydrogen Bonding, Peptidyl-Dipeptidase A, Models, Molecular, Protein Binding, Receptors, Virus, Salts, Water, Sequence Alignment, Conserved Sequence, Crystallography, X-Ray, Evolution, Molecular, Severe acute respiratory syndrome-related coronavirus, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks